Administration of N-acetylcysteine (Nac) as Adjunctive Therapy for Covid-19 Patients by Improving Oxidative Stress and Inflammation through Assessment of Ldh, Crp, D-dimer, and Ferritin

Susanthy Djajalaksana; Aditya Sri Listyoko; Magdalena; Anthony Christanto

doi:10.36948/ijfmr.2023.v05i04.4857

Administration of N-acetylcysteine (Nac) as Adjunctive Therapy for Covid-19 Patients by Improving Oxidative Stress and Inflammation through Assessment of Ldh, Crp, D-dimer, and Ferritin

Author(s)	Susanthy Djajalaksana, Aditya Sri Listyoko, Magdalena, Anthony Christanto
Country	Indonesia
Abstract	INTRODUCTION Lactate dehydrogenase (LDH), C-Reactive Protein (CRP), D-dimer and feritin are acute phase proteins which levels may rise in the presence of an inflammatory process of COVID-19. N-Acetylcysteine (NAC) is an antioxidant which has also been widely considered as adjunctive therapy in COVID-19. We aim to analyze the effect of NAC administration in improving oxidative stress and inflammation in COVID-19 through assessment of LDH, CRP, D-dimer, and feritin levels. METHOD A quasi-experimental study with pre-post design. LDH, CRP, D-dimer, and feritin levels were measured in admission and day 8 of administration of 5000 mg/72 hours of NAC. RESULT There is a significant decrease in CRP, LDH, D-dimer and Ferritin levels between admission and day 8 of NAC therapy. CRP levels were reduced from 185.31 ± 181.30 to 97.60 ± 161.86 (p<0.001), LDH levels were reduced from 4.65 ± 4.13 to 1.87 ± 0.96 (p<0.001), D-dimer levels were reduced from 185.31 ± 181.30 to 97.60 ± 161.86 (p<0.001) and Ferritin levels were reduced from 4.65 ± 4.13 to 1.87 ± 0.96 (p<0.001). DISCUSSION There is a significant decrease of LDH, CRP, D-dimer, and feritin levels from day-1 (admission) to day-8 of NAC administration in accordance with existing theories. This implies the ability of NAC to reduce oxidative stress and inflammation in COVID-19 patients. CONCLUSION There was a decrease in CRP, LDH, D-dimer and Ferritin after administration of NAC in COVID-19 patients and a positive correlation between severity and mortality towards acute phase protein in COVID-19 patients.
Keywords	COVID-19, N-Acetylcysteine, Acute phase protein, Inflammatory markers
Field	Medical / Pharmacy
Published In	Volume 5, Issue 4, July-August 2023
Published On	2023-08-01
Cite This	Administration of N-acetylcysteine (Nac) as Adjunctive Therapy for Covid-19 Patients by Improving Oxidative Stress and Inflammation through Assessment of Ldh, Crp, D-dimer, and Ferritin - Susanthy Djajalaksana, Aditya Sri Listyoko, Magdalena, Anthony Christanto - IJFMR Volume 5, Issue 4, July-August 2023. DOI 10.36948/ijfmr.2023.v05i04.4857
DOI	https://doi.org/10.36948/ijfmr.2023.v05i04.4857
Short DOI	https://doi.org/gskjq7

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2 Cover Page Vol 6 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Administration of N-acetylcysteine (Nac) as Adjunctive Therapy for Covid-19 Patients by Improving Oxidative Stress and Inflammation through Assessment of Ldh, Crp, D-dimer, and Ferritin

Share this